刘传军

男， 武汉大学， 教授/研究员/教授级高工或同等级别

学习/工作经历

1998.09-2002.06 吉林大学化学学院 本科
2002.09-2007.06 吉林大学化学学院 硕博连读研究生; 导师：张希院士
2007.09-2010.08 德国马普高分子研究所 博士后; 合作导师：Hans-Jürgen Butt教授
2010.09-2022.11 武汉大学化学与分子科学学院 副教授、博士生导师
2022.12 至今 武汉大学化学与分子科学学院 教授、博士生导师

研究领域和兴趣

生物医用高分子材料

主要业绩

武汉大学化学与分子科学学院教授，博士生导师，主要研究方向为生物医用高分子材料。主持国家自然科学基金项目4项，湖北省自然科学基金面上项目1项。2012年入选湖北省楚天学子。至今已在 Angew Chem Int Ed, Adv Mater, Adv Funct Mater，Materials Today, ACS Nano等期刊发表SCI论文50多篇，文章多次入选ESI高被引。

代表成果

1. Yan X, Li K, Xie TQ, Jin XK, Zhang C, Li QR, Feng J, Liu CJ*, Zhang XZ*. Bioorthogonal “Click and Release” Reaction-Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy. Angew. Chem. Int. Ed., 2024, 63, e202318539.
2. Jin XK, Zhang SM, Liang JL, Zhang XK, Qin YT, Huang QX, Liu CJ*, Zhang XZ*. A PD-L1-targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition-mediated Synergistic Antitumor Metabolic and Immune Therapy. Advanced Materials, 2024, 36, 2309094.
3. Jin XK, Liang JL, Zhang SM, Huang QX, Zhang SK, Liu CJ*, Zhang XZ*. Orchestrated copper-based nanoreactor for remodeling tumor microenvironment to amplify cuproptosis-mediated antitumor immunity in colorectal cancer. Materials Today, 2023, 68, 108.
4. Jin XK, Liang JL, Zhang SM, Ji P, Huang QX, Qin YT, Deng XC, Liu CJ*, Zhang XZ*. Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation via activation of the STING pathway for enhanced immunotherapy. Materials Horizons, 2023, 10, 4365.
5. Li MJ, Gao F, Huang QX, Feng J, Liu CJ*, Gong SL*, Zhang XZ*. Natural killer cell-mimicking nanomaterial for overcoming the multidrug resistance of tumor via cascade catalysis. SCIENCE CHINA Materials, 2023, 66, 1215.
6. Li K, Liu MD, Huang QX, Liu CJ*, Zhang XZ *. Nanoplatforms with donor-acceptor Stenhouse adduct molecular switch for enzymatic reactions remotely controlled with near-infrared light. SCIENCE CHINA Materials, 2023, 66, 375.
7. 3. Peng SY, Chen L, Deng RH, Li H, Liu XH, Zheng DW, Wu CC, Liu CJ*, Sun ZJ*, Zhang XZ*. Non-depleting reformation of immunosuppressive myeloid cells to broaden the application of anti-PD therapy. Nanoscale, 2021, 13, 4420.
8. Li K, Liu CJ*, Zhang XZ*. A modular theranostic platform for tumor therapy and its metabolic studies. Advanced Drug Delivery Reviews, 2020, 160, 36.
9. Kuang J, Song W, Yin J, Zeng X, Han S, Zhao YP, Tao J, Liu CJ,* He XH*, Zhang XZ. iRGD Modified Chemo-immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma. Adv. Funct. Mater., 2018, 28, 1800025.
10. Song W, Kuang J, Li CX, Zhang M, Zheng DW, Zeng X, Liu CJ*, Zhang XZ*. Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication. ACS Nano 2018, 12, 1978.

*以上信息由高级会员个人更新和维护。